180 related articles for article (PubMed ID: 17889226)
1. Sequential regimens for Helicobacter pylori eradication.
Moayyedi P
Lancet; 2007 Sep; 370(9592):1010-2. PubMed ID: 17889226
[No Abstract] [Full Text] [Related]
2. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
[TBL] [Abstract][Full Text] [Related]
3. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
4. Maintenance of Helicobacter pylori eradication rates with triple therapy over 12 years in a Spanish hospital.
Gisbert JP; McNicholl AG
Helicobacter; 2012 Apr; 17(2):160-1. PubMed ID: 22404448
[No Abstract] [Full Text] [Related]
5. [New therapeutic strategies against Helicobacter pylori].
Kang BK; Park SM; Kim BW
Korean J Gastroenterol; 2014 Mar; 63(3):146-50. PubMed ID: 24651587
[TBL] [Abstract][Full Text] [Related]
6. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG
Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551
[TBL] [Abstract][Full Text] [Related]
7. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
[TBL] [Abstract][Full Text] [Related]
8. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.
Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2011 Sep; 34(6):604-17. PubMed ID: 21745241
[TBL] [Abstract][Full Text] [Related]
9. [Eradication therapy for Helicobacter pylori infection: review of world trends].
Maev IV; Kucheriavyĭ IuA; Andreev DN; Barkalova EV
Ter Arkh; 2014; 86(3):94-9. PubMed ID: 24779078
[TBL] [Abstract][Full Text] [Related]
10. A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea.
Lee JW; Kim N; Kim JM; Nam RH; Kim JY; Lee JY; Lee DH; Jung HC
Scand J Gastroenterol; 2014 Aug; 49(8):917-24. PubMed ID: 24988873
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of azythromicin-based triple therapy for Helicobacter pylori infection: a retrospective study.
Pellicano R; Astegiano M; Smedile A; Saracco G; Berrutti M; Morgando A; Fadda M; Repici A; Fagoonee S; Rizzetto M
Panminerva Med; 2008 Sep; 50(3):259-60. PubMed ID: 18927531
[No Abstract] [Full Text] [Related]
12. Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates.
Rakici H; Akdoğan RA; Bedir R; Copur A; Yilmaz A
J Dig Dis; 2014 Sep; 15(9):508-13. PubMed ID: 24980811
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of PPI, levofloxacin and amoxicillin in the eradication of Helicobacter pylori compared to conventional triple therapy at a Venezuelan hospital.
Dib J; Alvarez B; Mendez L; Cruz ME
Arab J Gastroenterol; 2013 Sep; 14(3):123-5. PubMed ID: 24206741
[TBL] [Abstract][Full Text] [Related]
14. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.
Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1255-68. PubMed ID: 22017749
[TBL] [Abstract][Full Text] [Related]
15. Reflux masquerader: acute Helicobacter pylori infection in neonates and infants.
Frem JC; Gold BD; Shehata BM; Cole CR
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):589-92. PubMed ID: 18493216
[No Abstract] [Full Text] [Related]
16. [What is currently the Helicobacter pylori eradication therapy of choice? Triple therapy (PPI, amoxicillin and clarithromycin) or sequential therapy (PPI and amoxicillin for 5 days followed by PPI, clarithromycin and metronidazole for a further 5 days)?].
Sánchez-Delgado J
Gastroenterol Hepatol; 2009 Jan; 32(1):68-9. PubMed ID: 19174106
[No Abstract] [Full Text] [Related]
17. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
[TBL] [Abstract][Full Text] [Related]
18. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
Buzás GM; Józan J
Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
[TBL] [Abstract][Full Text] [Related]
19. Is there still a role for empiric first-line triple therapy using proton pump inhibitor, amoxicillin and clarithromycin for Helicobacter pylori infection in Singapore? Results of a time trend analysis.
Ang TL; Wang L; Ang D; Chiam P; Fock KM; Teo EK
J Dig Dis; 2013 Feb; 14(2):100-4. PubMed ID: 23253473
[TBL] [Abstract][Full Text] [Related]
20. The best and worst treatments for Helicobacter pylori.
Braden B
BMJ; 2015 Aug; 351():h4146. PubMed ID: 26290321
[No Abstract] [Full Text] [Related]
[Next] [New Search]